Atria Investments
CHRS icon

Atria Investments’s Coherus Oncology CHRS Stock Holding History

Atria Investments’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$26.4K Sell
21,827
-4,599
-17% -$6.29K ﹤0.01% 2134
2026
Q2 		$37K Sell
26,426
-10,965
-29% -$17.9K ﹤0.01% 2108
2026
Q1 		$63.2K Buy
+37,391
New +$66.4K ﹤0.01% 2021

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
RE
Rydar Equities Weatherford, Texas $194M AUM 23.21% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.51B AUM 13.02% 1-Year Est. Return

Atria Investments's CHRS Position: Q3 2026 in Review

Atria Investments reduced its Coherus Oncology (CHRS) stake by 17% in Q3 2026, selling an estimated $6.29K and leaving 21,827 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

Atria Investments first reported a position in CHRS in Q1 2026 and has held it in 3 quarters since. The position peaked at $63.2K in Q1 2026. 9 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.

  • Atria Investments held 21,827 shares of Coherus Oncology worth $26.4K as of Q3 2026.
  • Atria Investments sold 4,599 Coherus Oncology shares in Q3 2026, an estimated $6.29K.
  • Coherus Oncology made up ﹤0.01% of Atria Investments's portfolio in Q3 2026, its #2134 holding.
  • Atria Investments first reported a position in Coherus Oncology in Q1 2026 and has held it in 3 quarters since.
  • Atria Investments's Coherus Oncology position peaked at $63.2K in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.

Based on Atria Investments's 13F filing for Q3 2026, filed 15 Oct 2026.